Identification of Neonates at Risk for Hazardous Hyperbilirubinemia: Emerging Clinical Insights

Pediatric Clinics of North America

Volumn 56, Issue 3, 2009, Pages 671-687

  Watchko, Jon F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Breast milk feeding; East Asian ethnicity; Glucose 6 phosphate dehydrogenase deficiency; Jaundice; Kernicterus; Late preterm gestation

Indexed keywords

BILIRUBIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE 1A1; ORGANIC ANION TRANSPORTER 2;

ASIAN; BRAIN DAMAGE; BRAIN HEMATOMA; BREAST FEEDING; CEREBRAL PALSY; ENAMEL HYPOPLASIA; ENZYME ACTIVITY; FAMILY HISTORY; GAZE PARALYSIS; GENE MUTATION; GENETIC POLYMORPHISM; GESTATIONAL AGE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEARING LOSS; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; KERNICTERUS; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PHOTOTHERAPY; REVIEW; RISK ASSESSMENT; RISK FACTOR; BLOOD; ETHNOLOGY; NEWBORN JAUNDICE; PREMATURITY;

ASIAN CONTINENTAL ANCESTRY GROUP; BILIRUBIN; BREAST FEEDING; ERYTHROBLASTOSIS, FETAL; GESTATIONAL AGE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; INFANT, PREMATURE; KERNICTERUS; PHOTOTHERAPY; RISK FACTORS;

EID: 67649087950     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2009.04.005     Document Type: Review

References (103)

1. Perlstein M.A. The late clinical syndrome of posticteric encephalopathy. Pediatr Clin North Am 7 3 (1960) 665-687
2. Watchko J.F. Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns. Neuromolecular Med 8 4 (2006) 513-529
3. Maisels M.J., and Newman T.B. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 96 4 (1995) 730-733
4. Bhutani V.K., Johnson L.H., Maisels M.J., et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 24 10 (2004) 650-662
5. Ip S., Chung M., Kulig J., et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 114 1 (2004) e130-e153
6. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr 89 10 (2000) 1213-1217
7. Hansen T.W.R. Kernicterus: an international perspective. Semin Neonatol 7 2 (2002) 103-109
8. Kaplan M., and Hammerman C. Understanding and preventing severe hyperbilirubinemia: is bilirubin neurotoxicity really a problem in the developed world?. Clin Perinatol 31 3 (2004) 555-575
9. Ryan A.S., Wenjun Z., and Acosta A. Breastfeeding continues to increase into the new millennium. Pediatrics 110 6 (2002) 1103-1109
10. Curtin S.C., and Kozak L.J. Decline in US cesarean delivery rate appears to stall. Birth 25 4 (1998) 259-262
11. Newman T.B., Xiong B., Gonzales V.M., et al. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 154 11 (2000) 1140-1147
12. Huang M.J., Kua K.E., Teng H.C., et al. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res 56 5 (2004) 682-689
13. Newman T.B., Liljestrand P., and Escobar G.J. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med 159 2 (2005) 113-119
14. Keren R., Luan X., Friedman S., et al. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics 121 1 (2008) e170-e179
15. American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114 1 (2004) 297-316
16. Maisels M.J., DeRidder J.M., Kring E.A., et al. Routine transcutaneous bilirubin measurements combined with clinical risk factors improves the prediction of subsequent hyperbilirubinemia. J Perinatol (2009) in press
17. Watchko J.F. Hyperbilirubinemia and bilirubin toxicity in the late preterm infant. Clin Perinatol 33 4 (2006) 839-852
18. Kaplan M., Muraca M., Vreman H.J., et al. Neonatal bilirubin production-conjugation imbalance: effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity. Arch Dis Child Fetal Neonatal Ed 90 2 (2005) F123-F127
19. Kawade N., and Onish S. The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver. Biochem J 196 1 (1981) 257-260
20. Newman T.B., Escobar G.J., Gonzales V.M., et al. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics 104 5 (1999) 1198-1203
21. Bhutani V.K., Johnson L., Sivieri E.M., et al. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 103 1 (1999) 6-14
22. Keren R., Luan X., Tremont K., et al. Visual assessment of jaundice in term and late preterm infants. Arch Dis Child Fetal Neonatal Ed (2009) in press
23. Bhutani V.K., and Johnson L. Kernicterus in late preterm infants cared for as term healthy infants. Semin Perinatol 30 2 (2006) 89-97
24. Wang M.L., Dorer D.J., Fleming M.P., et al. Clinical outcomes of near-term infants. Pediatrics 114 2 (2004) 372-376
25. Neifert M.R. Prevention of breastfeeding tragedies. Pediatr Clin North Am 48 2 (2001) 273-297
26. American Academy of Pediatrics. Care of the neonate. In: Lockwood C.J., and Lemons J.A. (Eds). Guideline for perinatal care. 6th edition (2007), American Academy of Pediatrics, American College of Obstetrics and Gynecology, Elk Grove Village (IL) 227-230
27. Kivlahan C., and James E.J.P. The natural history of neonatal jaundice. Pediatrics 74 3 (1984) 364-370
28. Linn S., Schoenbaum S.C., Monson R.R., et al. Epidemiology of neonatal hyperbilirubinemia. Pediatrics 75 4 (1985) 770-774
29. Maisels M.J., Gifford K., Antle C.E., et al. Normal serum bilirubin levels in the newborn and the effect of breast feeding. Pediatrics 78 5 (1986) 837-843
30. Schneider A.P. Breast milk jaundice in the newborn. A real entity. JAMA 255 23 (1986) 3270-3274
31. Hansen T.W.R. Bilirubin production, breast-feeding and neonatal jaundice. Acta Paediatr 90 7 (2001) 716-723
32. Nielsen H.E., Haase P., Blaabjerg J., et al. Risk factors and sib correlation in physiological neonatal jaundice. Acta Paediatr 76 3 (1987) 504-511
33. Rubaltelli F.F. Unconjugated and conjugated bilirubin pigments during perinatal development IV: the influence of breast-feeding on neonatal hyperbilirubinemia. Biol Neonate 64 2-3 (1993) 104-109
34. De Carvalho M., Klaus M.H., and Merkatz R.B. Frequency of breastfeeding and serum bilirubin concentration. Am J Dis Child 136 8 (1982) 737-738
35. Yamauchi Y., and Yamanouchi I. Breast-feeding frequency during the first 24 hours after birth in full term neonates. Pediatrics 86 2 (1990) 171-175
36. Johnson L.H., Bhutani V.K., and Brown A.K. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 140 4 (2002) 396-403
37. Takimoto M., and Matsuda I. β-glucuronidase activity in the stool of newborn infant. Biol Neonate 18 1 (1971) 66-70
38. Gourley G.R. Perinatal bilirubin metabolism. In: Gluckman P.D., and Heymann M.A. (Eds). Perinatal and pediatric pathophysiology. A clinical perspective (1993), Hodder and Stoughton, Boston 437-439
39. Poland R.D., and Odell G.B. Physiologic jaundice: the enterohepatic circulation of bilirubin. N Engl J Med 284 1 (1971) 1-6
40. Gartner L.M., Lee K.-S., Vaisman S., et al. Development of bilirubin transport and metabolism in the newborn rhesus monkey. J Pediatr 90 4 (1977) 513-531
41. Gartner U., Goeser T., and Wolkoff A.W. Effect of fasting on the uptake of bilirubin and sulfobromopthalein by the isolated perfused rat liver. Gastroenterology 113 5 (1997) 1707-1713
42. Fevery J. Fasting hyperbilirubinemia: unraveling the mechanism involved. Gastroenterology 113 5 (1997) 1798-1800
43. Bertini G., Carlo C., Tronchin M., et al. Is breastfeeding really favoring early neonatal jaundice. Pediatrics 107 3 (2001) e41. http://www.pediatrics.org/cgi/content/full/107/3/e41 Available at:
44. Maisels M.J. Epidemiology of neonatal jaundice. In: Maisels M.J., and Watchko J.F. (Eds). Neonatal jaundice (2000), Harwood Academic Publishers, Amsterdam 37-49
45. Stevenson D.K., Bortoletti A.L., Ostrander C.R., et al. Pulmonary excretion of carbon monoxide in the human infant as an index of bilirubin production. IV: effects of breast-feeding and caloric intake in the first postnatal week. Pediatrics 65 6 (1980) 1170-1172
46. Hintz S.R., Gaylord T.D., Oh W., et al. Serum bilirubin levels at 72 hours by selected characteristics in breastfed and formula-fed term infants delivered by cesarean section. Acta Paediatr 90 7 (2001) 776-781
47. Watchko J.F. Vigintiphobia revisited. Pediatrics 115 6 (2005) 1747-1753
48. Watchko J.F. Genetics and the risk of neonatal hyperbilirubinemia. Pediatr Res 56 5 (2004) 677-678
49. Cui Y., Konig J., Leier I., et al. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 276 13 (2001) 9626-9630
50. Monaghan G., McLellan A., McGeehan A., et al. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn. J Pediatr 134 4 (1999) 441-446
51. Maruo Y., Nishizawa K., Sato H., et al. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics 103 6 (1999) 1224-1227
52. Beutler E. G6PD deficiency. Blood 84 11 (1994) 3613-3636
53. Valaes T. Neonatal jaundice in glucose-6-phosphate dehydrogenase deficiency. In: Maisels M.J., and Watchko J.F. (Eds). Neonatal jaundice (2000), Harwood Academic Publishers, Amsterdam 67-72
54. Valaes T. Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology. Acta Paediatr Suppl 394 (1994) 58-76
55. Kaplan M., and Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus. Semin Perinatol 28 5 (2004) 356-364
56. Oguniesi T.A., Dedeke I.O.F., Adekanmbi A.F., et al. The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre study. Niger J Med 16 4 (2007) 354-359
57. Chinevere T.D., Murray C.K., Grant E., et al. Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel. Mil Med 171 9 (2006) 905-907
58. Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood 111 1 (2008) 16-24
59. Lin Z., Fontaine J.M., Freer D.E., et al. Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency. Mol Genet Metab 86 1-2 (2005) 212-219
60. Kaplan M., Renbaum P., Levy-Lahad E., et al. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A 94 22 (1997) 12128-12132
61. Huang C.S., Chang P.F., Huang M.J., et al. Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronsyltransferase 1A1 gene, and neonatal hyperbilirubinemia. Gastroenterology 123 1 (2002) 127-133
62. Bosma P.J., Roy Chowdhury J., Bakker C., et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333 18 (1995) 1171-1175
63. Huang C.S. Molecular genetics of unconjugated hyperbilrubinemia in Taiwanese. J Biomed Sci 12 3 (2005) 445-450
64. Iolascon A., Faienza M.F., and Moretti A. UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis. Blood 91 3 (1998) 1093-1094
65. Watchko JF, Lin Z, Clark RH, et al. The complex multifactorial nature of significant hyperbilirubinemia in neonates. EPAS 2009;5500.2
66. Kaplan M., Herschel M., Hammerman C., et al. Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency. J Pediatr 149 1 (2006) 83-88
67. Newman T.B., Easterling J., Goldman E.S., et al. Laboratory evaluation of jaundice in newborns. Frequency, cost and yield. Am J Dis Child 144 3 (1990) 364-368
68. Kaplan M., Herschel M., Hammerman C., et al. Hyperbilirubinemia among African American glucose-6-phosphate dehydrogenase-efficient neonates. Pediatrics 114 2 (2004) e213-e219
69. A Planning Conference: Utility of Screening for G6PD Deficiency to Prevent Severe Neonatal Hyperbilirubinemia. Bethesda, MD, May 11-12, 2007.
70. Kaplan M., Merob P., and Regev R. Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol 28 6 (2008) 389-397
71. Padilla C.D., and Therrell B.L. Newborn screening in the Asia Pacific region. J Inherit Metab Dis 30 4 (2007) 490-506
72. Naiman J.L. Erythroblastosis fetalis. In: Oski F.A., and Naiman J.L. (Eds). Hematologic problems in the newborn (1982), W.B. Saunders, Philadelphia 326-332
73. Ozolek J.A., Watchko J.F., and Mimouni F. Prevalence and lack of clinical significance of blood group incompatibility in mothers with blood type A or B. J Pediatr 125 1 (1994) 87-91
74. Herschel M., Karrison T., Wen M., et al. Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobin test-negative neonates. Pediatrics 110 1 (2002) 127-130
75. Kaplan M., Na'amad M., Kenan A., et al. Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers. Pediatrics 123 1 (2009) e132-e137
76. Halbrecht I. Role of hemagglutinins anti-A and anti-B in pathogenesis of jaundice of the newborn (icterus neonatorum precox). Am J Dis Child 68 4 (1944) 248-249
77. Cashore W.J. Neonatal hyperbilirubinemia. In: Oski F.A., DeAngelis C.D., Feigin R.D., et al. (Eds). Principles and practice of pediatrics (1990), J.B. Lippincott, Philadelphia 399-408
78. Maisels M.J., and McDonagh A.F. Phototherapy for neonatal jaundice. N Engl J Med 358 9 (2008) 920-928
79. Hammerman C., Vreman H.J., Kaplan M., et al. Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis. Acta Paediatr 85 11 (1996) 1351-1353
80. Gottstein R., and Cooke R.W. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 88 1 (2003) F6-F10
81. Watchko J.F. Indirect hyperbilirubinemia in the neonate. In: Maisels M.J., and Watchko J.F. (Eds). Neonatal jaundice (2000), Harwood Academic Publishers, Amsterdam 51-66
82. Hubinont P.O., Bricoult A., and Ghysdael P. ABO mother-infant incompatibilities. Am J Obstet Gynecol 79 3 (1960) 593-600
83. Leistikow E.A., Collin M.F., Savastano G.D., et al. Wasted health care dollars. Routine cord blood type and Coombs' testing. Arch Pediatr Adolesc Med 149 10 (1995) 1147-1151
84. Quinn M.W., Weindling A.M., and Davidson D.C. Does ABO incompatibility matter?. Arch Dis Child 63 10 (1988) 1258-1260
85. Judd W.J., Luban N.L.C., Ness P.M., et al. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient. Transfusion 30 2 (1990) 175-183
86. Ho N.K. Neonatal jaundice in Asia. Baillieres Clin Haematol 5 1 (1992) 131-142
87. Huang C.S., Luo G.A., Huang M.J., et al. Variations of the bilirubin uridine-glucuronosyl transferase 1A1 gene in healthy Taiwanese. Pharmacogenetics 10 6 (2000) 539-544
88. Huang C.S., Chang P.F., Huang M.J., et al. Relationship between bilirubin UDP-glucuronosyl transferase 1A1 gene and neonatal hyperbilirubinemia. Pediatr Res 52 4 (2002) 601-605
89. Yamamoto K., Sato H., Fujiyama Y., et al. Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II. Biochim Biophys Acta 1406 3 (1998) 267-273
90. Kim E.Y., Cho D.Y., Shin H.J., et al. Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populations. Clin Chim Acta 388 1-2 (2008) 68-72
91. Newman T.B., Liljestrand P., and Escobar G.J. Jaundice noted in the first 24 hours after birth in a managed care organization. Arch Pediatr Adolesc Med 156 12 (2002) 1244-1250
92. Odell G.B. Neonatal hyperbilirubinemia (1980), Grune and Stratton, New York p. 56-7
93. Wright K., Tarr P.I., Hickman R.O., et al. Hyperbilirubinemia secondary to delayed absorption of intraperitoneal blood following intrauterine transfusion. J Pediatr 100 2 (1982) 302-304
94. Rajagopalan I., and Katz B.Z. Hyperbilirubinemia secondary to hemolysis of intrauterine intraperitoneal blood transfusion. Clin Pediatr 23 9 (1984) 511-512
95. Gale R., Seidman D.S., Dollberg S., et al. Epidemiology of neonatal jaundice in the Jerusalem population. J Pediatr Gastroenterol Nutr 10 1 (1990) 82-86
96. Khoury M.J., Calle E.E., and Joesoef R.M. Recurrence risk of neonatal hyperbilirubinemia in siblings. Am J Dis Child 142 10 (1988) 1065-1069
97. Maisels M.J. Jaundice in the newborn. Pediatr Rev 3 X (1982) 305-319
98. Katz M.A., Kanto W.P., and Korotkin J.H. Recurrence rate of ABO hemolytic disease of the newborn. Obstet Gynecol 59 5 (1982) 611-614
99. Ebbesen F., and Mortensen B.B. Difference in plasma bilirubin concentration between monozygotic and dizygotic newborn twins. Acta Paediatr 92 5 (2003) 569-573
100. Bhutani V., Gourley G.R., Adler S., et al. Non-invasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 106 2 (2000) e17
101. Maisels M.J., Bhutani V.K., Bogen D., et al. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation-an update with clarifications. Pediatrics (2009) in press
102. Eggert L.D., Wiedmeier S.E., Wilson J., et al. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics 117 5 (2006) e855-e862
103. Kuzniewicz M.W., Escobar G.J., and Newman T.B. The impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use in a managed care organization. Pediatrics (2009) in press